Categories Finance

Merck held talks to buy biotech MoonLake for over $3 billion, FT reports

Post Content

Related posts:

  1. Exclusive-Germany’s Merck KGaA in talks to buy US cancer biotech firm Springworks, sources say
  2. This Biotech Stock Is Jumping 20%. Why a $3 Billion Merck Offer Could Be a Win-Win.
  3. Is MoonLake Immunotherapeutics (MLTX) Among the Best Guru Stocks to Buy According to Wall Street Analysts?
  4. These Stocks Are Moving the Most Today: Nvidia, TSMC, Tesla, Credo Technology, Moonlake, and More

About The Author

admin
http://digitalgroundmedia.com

More From Author

Ninja’s star Creami ice cream maker is on sale for $169

How to Stop Social Media Platforms From Tracking You When You Share Posts

Astronomers Watch in Amazement as 2 Planets Smash Into Each Other Around Nearby Star

Leave a Reply

Your email address will not be published. Required fields are marked *